Amlodipine + indapamide

Amlodipine + indapamide has been studied in 2 papers since 2025: 2 trials in people; 1 in the past year. The newest story, Oct 30, 2026: “Triple blood pressure pill reached near-full effect in two weeks”.

Intervention

2 papers study it4 more mention it6 findingsUpdated

PubChemPubChemChEBIChEBI

4 new papers in 30 daysSee all 6

“The mean SBP decreased by 20.9, 24.7, and 29.3 mmHg (p < 0.001)”
Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 YearsCureus2025doi:10.7759/cureus.92756

None of its findings points the other way.

  • 1 lab in 1 country
  • Human trial2

Studies in people

1 study gave amlodipine + indapamide to people and measured what changed.

What did studies of Amlodipine + indapamide find?

3

Studies of Amlodipine + indapamide measured 3 outcomes; the most studied are patient-perceived health status (1 study), diastolic blood pressure (1) and systolic blood pressure (1).

Patient-perceived health status

upin humans1

1 study
  1. Amlodipine + indapamide improves patient-perceived health status in humans (55.9 ± 17.0 at baseline to 78.9 ± 14.1 at 12 weeks).

    “VAS scores (mean ± SD) increased from 55.9 ± 17.0 at baseline, 68.2 ± 14.5 at two weeks, 72.7 ± 14.6 at four weeks, and 78.9 ± 14.1 at 12 weeks (p < 0.001).”

    Human trial12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

  2. Amlodipine + indapamide improves patient-perceived health status in humans (isolated systolic hypertension).

    “VAS scores improved significantly, reflecting enhanced patient-perceived health status.”

    Human trialisolated systolic hypertensionindapamide 1.5 mg and amlodipine 5 mg once daily12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

Diastolic blood pressure

downin humans1

1 study
  1. Amlodipine + indapamide decreases diastolic blood pressure in humans (-12.9 mmHg).

    “At 12 weeks, the mean SBP further declined to 127.4 ± 17.9 mmHg, corresponding to a total reduction of -29.3 mmHg (95% CI: -30.7 to -27.9; p < 0.001), while DBP dropped to 75.6 ± 10.2 mmHg, with a mean change of -12.9 mmHg (95% CI: -14.1 to -11.7; p < 0.001).”

    Human trial12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

  2. Amlodipine + indapamide decreases diastolic blood pressure in humans (isolated systolic hypertension) (-12.9 mmHg at 12 weeks (p < 0.001)).

    “mean diastolic BP (DBP) declined by 8.1, 10.4, and 12.9 mmHg (p < 0.001) at two, four, and 12 weeks, respectively.”

    Human trialisolated systolic hypertensionindapamide 1.5 mg and amlodipine 5 mg once daily12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

More on Diastolic blood pressure

Systolic blood pressure

downin humans1

1 study
  1. Amlodipine + indapamide decreases systolic blood pressure in humans (-29.3 mmHg).

    “At 12 weeks, the mean SBP further declined to 127.4 ± 17.9 mmHg, corresponding to a total reduction of -29.3 mmHg (95% CI: -30.7 to -27.9; p < 0.001), while DBP dropped to 75.6 ± 10.2 mmHg, with a mean change of -12.9 mmHg (95% CI: -14.1 to -11.7; p < 0.001).”

    Human trial12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

  2. Amlodipine + indapamide decreases systolic blood pressure in humans (isolated systolic hypertension) (-29.3 mmHg at 12 weeks (p < 0.001)).

    “The mean SBP decreased by 20.9, 24.7, and 29.3 mmHg (p < 0.001)”

    Human trialisolated systolic hypertensionindapamide 1.5 mg and amlodipine 5 mg once daily12 weeksn = 185

    Real-World Evaluation of the Efficacy and Tolerability of a Fixed-Dose Combination of Amlodipine and Indapamide in Patients Over 55 Years

    Cureus

More on Systolic blood pressure

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 44 papers in 12 months
ESC Congress 2026 Abstract

Triple blood pressure pill reached near-full effect in two weeks

In two randomized trials involving 3,299 adults with hypertension, a three-drug pill achieved virtually all its blood pressure reduction within two weeks.In two randomized trials involving 3,299 adults with hypertension, a three-drug pill achieved virtually all its blood pressure reduction within two weeks.

Randomized trial · 3,299 peopleInterventions
ESC Congress 2026 Abstract

Low-dose triple pill lowered blood pressure alone or added on

The pill lowered the upper blood pressure reading by 15 mmHg and the lower by 7 mmHg versus placebo at six weeks.The pill lowered the upper blood pressure reading by 15 mmHg and the lower by 7 mmHg versus placebo at six weeks.

Randomized trial · 1,670 peopleInterventions
ESC Congress 2026 Abstract

Three-drug pill reduced blood pressure swings after brain bleed

The spread of upper blood pressure readings, measured by standard deviation, was 2.05 mmHg lower with the pill than with placebo.The spread of upper blood pressure readings, measured by standard deviation, was 2.05 mmHg lower with the pill than with placebo.

Randomized trial · 1,557 peopleInterventions